FDA Adverse Event Injury Summary report: N

DS3 SPINE 5ML US

MDR report key: 3911584 · Received June 27, 2014

Report

Report Number
1219930-2014-00487
Event Type
Injury
Date Received
June 27, 2014
Date of Event
May 4, 2014
Report Date
June 4, 2014
Manufacturer
COVIDIEN, FORMERLY US SURGICAL
Product Code
NQR
PMA / PMN Number
P040034
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

PROCEDURE: SPINE. ON (B)(6) 2014, CLINICAL AFFAIRS BECAME AWARE OF A SERIOUS ADVERSE EVENT ASSOCIATED WITH ONE OF COVIDIENS PRODUCT LINES AS PART OF THE (B)(6) POST-APPROVAL STUDY. TWO BOXES WERE OPENED AND THE SITE WAS UNABLE TO DETERMINE WHICH WAS USED. SUBJECT NUMBER: (B)(6). ONSET DATE: (B)(6)-2014. RESOLVED: CONTINUING. SEVERITY: MILD. RELATIONSHIP TO DEVICE: DEFINITE. OUTCOME: CONTINUING. SUMMARY OF EVENTS: SUBJECT (B)(6) IS AN (B)(6) CAUCASIAN MALE WITH A PAST MEDICAL HISTORY OF LOW BACK PAIN AND DEGENERATIVE DISK DISEASE. THE SUBJECT HAD PREVIOUS SURGERY AT C3/4 AND HAD A LOOSE SPINOUS PROCESS REMOVED AT T2. ON (B)(6) 2014, THE SUBJECT WAS ADMITTED TO (B)(6), WHERE DR. (B)(6) PERFORMED A FORAMINOTOMY AND DECOMPRESSIVE PROCEDURE AT L2-S1 TO TREAT SPINAL STENOSIS. DURING THE PROCEDURE: AN INCIDENTAL DURAL TEAR OCCURRED, WHICH WAS CLOSED WITH SUTURES. THE LENGTH OF THE INCISION IS UNK. DURAGEN WAS PLACED OVER TH TEAR, AND THE AREA WAS THEN SEALED WITH DURASEAL (AMOUNT UNK). ONCE A WATERTIGHT CLOSURE WAS OBTAINED, THE WOUND WAS THEN CLOSED WITH SUTURES. A BLACK DRAIN WAS PLACED. ON (B)(6) 2014 (POST-OP DAT (B)(6)), SWELLING AND TENDERNESS AT THE SURGICAL SITE WAS NOTED. THE EVENT WAS DIAGNOSED AS A CSF LEAK AND TREATED WITH A BLOOD PATCH. THE EVENT IS CURRENTLY ONGOING. THE PT CATEGORIZED THIS EVENT WAS DEFINITELY RELATED TO DURASEAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
376266 DS3 SPINE 5ML US DURASEAL NQR COVIDIEN, FORMERLY US SURGICAL NA

Patients

Seq Age Sex Outcome Treatment
1 83 YR Other